
Study finds potential therapeutic target for prostate cancers with PTEN mutation
PTEN, a tumour suppressor gene mutated in approximately 20% of primary prostate cancers, and in…
PTEN, a tumour suppressor gene mutated in approximately 20% of primary prostate cancers, and in…